|
ARIH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.310400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082220E-01 |
| Normal-vs-Stage2 |
2.889800E-01 |
| Normal-vs-Stage3 |
1.300520E-03 |
| Normal-vs-Stage4 |
1.218250E-04 |
| Stage1-vs-Stage2 |
8.359200E-01 |
| Stage1-vs-Stage3 |
2.879700E-02 |
| Stage1-vs-Stage4 |
3.687800E-02 |
| Stage2-vs-Stage3 |
1.479410E-01 |
| Stage2-vs-Stage4 |
8.438300E-02 |
| Stage3-vs-Stage4 |
4.850400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.985700E-02 |
| Normal-vs-AfricanAmerican |
1.141400E-01 |
| Normal-vs-Asian |
2.516400E-01 |
| Caucasian-vs-AfricanAmerican |
9.999800E-01 |
| Caucasian-vs-Asian |
8.904400E-01 |
| AfricanAmerican-vs-Asian |
8.788800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.936260E-02 |
| Normal-vs-Female |
6.885200E-01 |
| Male-vs-Female |
9.928100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.347560E-01 |
| Normal-vs-Extreme_Weight |
2.064000E-02 |
| Normal-vs-Obese |
1.083640E-01 |
| Normal-vs-Extreme_Obese |
4.423800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.086400E-01 |
| Normal_Weight-vs-Obese |
7.843000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.438200E-01 |
| Extreme_Weight-vs-Obese |
5.280600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.196400E-01 |
| Obese-vs-Extreme_Obese |
5.509800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.367600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.355030E-01 |
| Normal-vs-Age(61-80Yrs) |
2.857700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.099540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.673900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.632090E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.725000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.844000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.545500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.898800E-01 |
| Normal-VS-Type2 PRCC |
2.57569999773111E-08 |
| Normal-VS-KIRP CIMP |
4.574400E-01 |
| Normal-VS-Unclassified PRCC |
1.729560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.60660049100636E-10 |
| Type1 PRCC-VS-KIRP CIMP |
5.550000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.306100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.677810E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.379890E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.280600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.187400E-04 |
| Normal-vs-N1 |
2.825800E-04 |
| Normal-vs-N2 |
2.741200E-03 |
| N0-vs-N1 |
4.579800E-01 |
| N0-vs-N2 |
2.340200E-01 |
| N1-vs-N2 |
4.273000E-01 |
|
|
